Does The Current Dip In Pfizer Stock Offer A Buying Opportunity? |
February 11, 2022 | February 2022 Bond Updates |
The stock price of Pfizer has seen a fall of 8% over the last month, while it is down over 3% in a week. The recent decline can be attributed to the company’s mixed Q4 results, with sales falling below, and earnings above, the street estimates. Pfizer’s revenue of $23.8 billion in Q4 was up 106%... |
View more at: https://www.forbes.com/sites/greatspeculations/2022/02/11/does-the-current-dip-in-pfizer-stock-offer-a-buying-opportunity/ |
Related News |